CD8A and cancer: Somatic missense or loss-of-function mutations, microdeletions within the HLA region, or the loss of one copy of chromosome 6 could potentially act as immune escape mechanisms, thereby promoting cancer growth and resistance to immunotherapy.56 The mutant or lost alleles may not be available inside the cancer cell to functionally present the neoantigen peptide fragment to CD8-positive T cells.